Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
20
CLOV Quote, Financials, Valuation and Earnings
Last price:
$2.00
Seasonality move
:
-8.12%
Day range:
$1.93 - $2.03
52-week range:
$1.93 - $3.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.53x
P/B ratio:
3.35x
Volume:
6.6M
Avg. volume:
6.1M
1-year change:
-45.05%
Market cap:
$1B
Revenue:
$1.9B
EPS (TTM):
-$0.17
Analysts' Opinion
-
Consensus RatingClover Health Investments Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $3.15, Clover Health Investments Corp. has an estimated upside of 57.5% from its current price of $2.00.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $2.75 representing 100% downside risk from its current price of $2.00.
Fair Value
-
According to the consensus of 3 analysts, Clover Health Investments Corp. has 57.5% upside to fair value with a price target of $3.15 per share.
CLOV vs. S&P 500
-
Over the past 5 trading days, Clover Health Investments Corp. has overperformed the S&P 500 by 0.85% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Clover Health Investments Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Clover Health Investments Corp. has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Clover Health Investments Corp. reported revenues of $487.7M.
Earnings Growth
-
Clover Health Investments Corp. earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Clover Health Investments Corp. reported earnings per share of -$0.10.
Enterprise value:
1B
EV / Invested capital:
3.35x
Price / LTM sales:
0.53x
EV / EBIT:
--
EV / Revenue:
0.54x
PEG ratio (5yr expected):
-0.13x
EV / Free cash flow:
-14.98x
Price / Operating cash flow:
57.66x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-15.06%
Net Income Margin (TTM):
-4.45%
Return On Equity:
-25.6%
Return On Invested Capital:
-25.6%
Operating Margin:
-10.11%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $1.3B | $1.4B | $1.9B | $336.9M | $487.7M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$184.4M | -$46M | -$85.5M | -$21.5M | -$49.3M | |
| EBITDA | -$205.8M | -$43.6M | -- | -$21.1M | -- | |
| Diluted EPS | -$0.44 | -$0.09 | -$0.17 | -$0.04 | -$0.10 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $752.5M | $625M | $428M | $343.1M | $307.9M | |
| Total Assets | $950.8M | $808.6M | $570.7M | $580.7M | $541M | |
| Current Liabilities | $372.6M | $431.5M | $261.1M | $213.5M | $208.8M | |
| Total Liabilities | $411.5M | $451.7M | $284.3M | $239.6M | $232.3M | |
| Total Equity | $539.3M | $356.9M | $286.4M | $341.1M | $308.7M | |
| Total Debt | $27.8M | $5.9M | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$144.7M | $34.8M | -$66.9M | -$85.8M | -$68.2M | |
| Cash From Investing | $140M | $565K | $4.1M | -$1.4M | -$35M | |
| Cash From Financing | -$5.1M | -$17.4M | -$53.4M | -$6.1M | -$8.6M | |
| Free Cash Flow | -$145.2M | $33.3M | -$69M | -$86.1M | -$68.7M | |
CLOV
Sector
Market Cap
$1B
$25.3M
Price % of 52-Week High
51.02%
49.41%
Dividend Yield
0%
0%
Shareholder Yield
4.46%
-1.6%
1-Year Price Total Return
-45.06%
-17.71%
Beta (5-Year)
2.149
0.490
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.05
200-day SMA
Sell
Level
$2.74
Bollinger Bands (100)
Sell
Level
2.14 - 2.98
Chaikin Money Flow
Sell
Level
-1.7B
20-day SMA
Sell
Level
$2.07
Relative Strength Index (RSI14)
Sell
Level
38.69
ADX Line
Sell
Level
17.18
Williams %R
Neutral
Level
-78.125
50-day SMA
Sell
Level
$2.33
MACD (12, 26)
Sell
Level
-0.08
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Sell
Level
-258.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.469)
Buy
CA Score
(Annual)
Level (0.561)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.0499)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.
Stock Forecast FAQ
In the current month, CLOV has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The CLOV average analyst price target in the past 3 months is $3.15.
-
Where Will Clover Health Investments Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Clover Health Investments Corp. share price will rise to $3.15 per share over the next 12 months.
-
What Do Analysts Say About Clover Health Investments Corp.?
Analysts are divided on their view about Clover Health Investments Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Clover Health Investments Corp. is a Sell and believe this share price will drop from its current level to $2.75.
-
What Is Clover Health Investments Corp.'s Price Target?
The price target for Clover Health Investments Corp. over the next 1-year time period is forecast to be $3.15 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is CLOV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Clover Health Investments Corp. is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CLOV?
You can purchase shares of Clover Health Investments Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Clover Health Investments Corp. shares.
-
What Is The Clover Health Investments Corp. Share Price Today?
Clover Health Investments Corp. was last trading at $2.00 per share. This represents the most recent stock quote for Clover Health Investments Corp.. Yesterday, Clover Health Investments Corp. closed at $2.00 per share.
-
How To Buy Clover Health Investments Corp. Stock Online?
In order to purchase Clover Health Investments Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CLOV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLOV
Sector
P/E ratio
--
22.85x
PEG ratio
-0.13x
-0.01x
P/B ratio
3.35x
1.78x
Price / LTM sales
0.53x
1.52x
Growth Metrics
CLOV
Sector
Revenue growth
44.75%
3.33%
Earnings growth
-112.47%
11.64%
Revenue (5-year growth)
22.9%
6.41%
Earnings forecast
-$0.05
-$0.20
Profitability
CLOV
Sector
Profitability FY 2025
--
$2.3M
Return on invested capital
-25.6%
-33.31%
Return on assets
-15.06%
-29.79%
Return on equity
-25.6%
-38.98%
Earnings Date
Last Earnings Date
Feb
26
Next Earnings Date
May
5
Estimated Next Earnings Date
May
28
Balance Sheet
CLOV
Sector
Total cash
$201.3M
$24.1M
Short term investments
$27M
$23.8M
Total assets
$541M
$70.1M
Long term debt
--
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
34
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
46
ZD alert for Mar 4
Ziff Davis, Inc. [ZD] is up 0.65% over the past day.
Buy
54
KORU alert for Mar 4
Direxion Daily MSCI South Korea Bull 3X Shares [KORU] is up 6.21% over the past day.
Sell
40
PSIX alert for Mar 4
Power Solutions International, Inc. [PSIX] is up 1.38% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
